208 related articles for article (PubMed ID: 15306533)
1. Effects of anticytokine therapy in a mouse model of chronic asthma.
Kumar RK; Herbert C; Webb DC; Li L; Foster PS
Am J Respir Crit Care Med; 2004 Nov; 170(10):1043-8. PubMed ID: 15306533
[TBL] [Abstract][Full Text] [Related]
2. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.
Yang G; Volk A; Petley T; Emmell E; Giles-Komar J; Shang X; Li J; Das AM; Shealy D; Griswold DE; Li L
Cytokine; 2004 Dec; 28(6):224-32. PubMed ID: 15566951
[TBL] [Abstract][Full Text] [Related]
4. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
5. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice.
Yang G; Li L; Volk A; Emmell E; Petley T; Giles-Komar J; Rafferty P; Lakshminarayanan M; Griswold DE; Bugelski PJ; Das AM
J Pharmacol Exp Ther; 2005 Apr; 313(1):8-15. PubMed ID: 15644434
[TBL] [Abstract][Full Text] [Related]
7. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
Ishikawa Y; Yoshimoto T; Nakanishi K
Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited airway remodeling in a murine model of chronic asthma.
Kim CH; Ahn JH; Kim SJ; Lee SY; Kim YK; Kim KH; Moon HS; Song JS; Park SH; Kwon SS
J Asthma; 2006; 43(5):345-53. PubMed ID: 16801138
[TBL] [Abstract][Full Text] [Related]
9. Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice.
Ma Y; Hayglass KT; Becker AB; Halayko AJ; Basu S; Simons FE; Peng Z
Allergy; 2007 Jun; 62(6):675-82. PubMed ID: 17508973
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
11. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
Chung KF
Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
[TBL] [Abstract][Full Text] [Related]
12. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production.
Hayashi N; Yoshimoto T; Izuhara K; Matsui K; Tanaka T; Nakanishi K
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14765-70. PubMed ID: 17766435
[TBL] [Abstract][Full Text] [Related]
13. [The relation between morphologic and functional airway changes in bronchial asthma].
Kips JC
Verh K Acad Geneeskd Belg; 2003; 65(4):247-65; discussion 265-9. PubMed ID: 14534940
[TBL] [Abstract][Full Text] [Related]
14. Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A(2) activity in a murine asthma model.
Ko HM; Kang NI; Kim YS; Lee YM; Jin ZW; Jung YJ; Im SY; Kim JH; Shin YH; Cho BH; Lee HK
Clin Exp Allergy; 2008 Feb; 38(2):357-64. PubMed ID: 18070157
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways.
Yang M; Kumar RK; Foster PS
J Immunol; 2009 Apr; 182(8):5107-15. PubMed ID: 19342691
[TBL] [Abstract][Full Text] [Related]
16. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
Hirota JA; Ask K; Fritz D; Ellis R; Wattie J; Richards CD; Labiris R; Kolb M; Inman MD
Clin Exp Allergy; 2009 Jan; 39(1):147-58. PubMed ID: 19032363
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).
Blanchard C; Mishra A; Saito-Akei H; Monk P; Anderson I; Rothenberg ME
Clin Exp Allergy; 2005 Aug; 35(8):1096-103. PubMed ID: 16120093
[TBL] [Abstract][Full Text] [Related]
18. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
19. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8+ T cells.
Polte T; Jagemann A; Foell J; Mittler RS; Hansen G
Clin Exp Allergy; 2007 Sep; 37(9):1374-85. PubMed ID: 17845419
[TBL] [Abstract][Full Text] [Related]
20. IL-4 induces IL-13-independent allergic airway inflammation.
Perkins C; Wills-Karp M; Finkelman FD
J Allergy Clin Immunol; 2006 Aug; 118(2):410-9. PubMed ID: 16890766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
